Synergistic Stent Graft System with AI, IoT, and Blockchain Integration

A novel stent graft system that combines advanced looped wire technology with AI, IoT, and blockchain innovations to enhance procedural outcomes and improve patient care.

The original patent disclosed a looped wire for advanced stent grafts, which improved the efficiency of endovascular aneurysm repair procedures. However, there remains a need for further integration of technologies to enhance real-time procedural optimization, device tracking, and data analytics. The new inventive concept addresses these limitations by incorporating AI, IoT, and blockchain technologies to create a more powerful and comprehensive system.

The synergistic stent graft system comprises a looped wire for endovascular aneurysm repair, an AI-powered guidance system for real-time procedural optimization, an IoT sensor module for adjusting the guidewire's trajectory, and a blockchain-based tracking module for monitoring device deployment. The system enables surgeons to navigate complex blood vessels with increased precision and accuracy, while also providing real-time data analytics and predictive insights for optimal stent deployment locations.

The new claims introduce the novel combination of AI, IoT, and blockchain technologies with the original looped wire concept, providing a synergistic system that offers improved procedural outcomes, enhanced data analytics, and increased device tracking capabilities. The inventive step lies in the integration of these distinct technologies to create a more comprehensive and effective stent graft system.

Alternative embodiments of the inventive concept could include the use of different AI algorithms for procedural optimization, varying IoT sensor configurations for real-time data collection, or the incorporation of additional technologies such as virtual or augmented reality for enhanced training and simulation. Variations of the system could also be designed for specific aneurysm types or patient populations.

The synergistic stent graft system has significant commercial potential in the medical device industry, particularly in the areas of endovascular aneurysm repair and minimally invasive surgery. The system's ability to enhance procedural outcomes, reduce complications, and provide real-time data analytics makes it an attractive solution for hospitals, clinics, and medical research institutions.